Home / Stocks / RAPP

RAPP insider trading

Rapport Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
5
Bought · 24 mo
$1.8M
Buys · last 90 days
0 · $0
Most recent buy
2025-09-15

Cluster buy detected

3 insiders bought RAPP within a short window (2025-09-11→2025-09-12), $1.6M in total — cluster score 62/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-26Yeleswaram Krishnaswamy
Chief Development Officer
Sold20,799$50.31$1.0M
2026-05-13TRV GP V, LLC
10% owner
Sold133,618$40.24$5.4M
2026-05-11TRV GP V, LLC
10% owner
Sold271,495$40.12$10.9M
2026-04-21TRV GP V, LLC
10% owner
Sold426,005$40.32$17.2M
2025-09-19Ceesay Abraham
Chief Executive Officer
Sold39,435$26.30$1.0M
2025-09-15Huber Reid Mcluster
Director
Bought20,400$24.48$499k
2025-09-15PAUL STEVEN Mcluster
Director
Bought41,666$24.65$1.0M
2025-09-11Young Wendy B.cluster
Director
Bought3,500$22.60$79k
2025-03-13Ignelzi Troy A.
Chief Financial Officer
Bought10,000$10.10$101k
2025-03-13Young Wendy B.
Director
Bought6,000$10.21$61k

Most active insider buyers

InsiderRoleBuysTotal bought
PAUL STEVEN MDirector1$1.0M
Huber Reid MDirector1$499k
Young Wendy B.Director2$140k
Ignelzi Troy A.Chief Financial Officer1$101k

See RAPP on the chart

Every insider buy and sell for RAPP plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.